• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[实体器官移植中侵袭性真菌感染的流行病学]

[Epidemiology of invasive fungal infection in solid organ transplant].

作者信息

Montejo Miguel

机构信息

Unidad de Enfermedades Infecciosas, Hospital Universitario de Cruces, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Baracaldo, Vizcaya, España.

出版信息

Rev Iberoam Micol. 2011 Jul-Sep;28(3):120-3. doi: 10.1016/j.riam.2011.06.003.

DOI:10.1016/j.riam.2011.06.003
PMID:21700231
Abstract

Despite advances made in the last decades, invasive fungal infections (IFI) continue to be a major cause of morbidity and mortality in solid organ transplant recipients. The most common pathogens causing IFI are Candida species, followed by Aspergillus and Cryptococcus. A shift in the epidemiology of IFI has been reported in the last few years. Non-Candida albicans Candida species and non-Aspergillus filamentous moulds have been increasingly observed in transplant patients. A change in the IFI onset time has also been described recently. In the RESITRA (Spanish Network of Infection in Transplantation) study, at least 50% of invasive aspergillosis (IA) infections and 40% of invasive Candida infections had been observed after 180 days of transplant. Some cases of cryptococcal infection, traditionally considered as a late onset infection, have been observed in the early post transplant period. Mortality due to IFI is still high, particularly in patients with IA. However, the progressive improvement achieved in diagnosis and prevention of IFI has led to a lower mortality rate.

摘要

尽管在过去几十年里取得了进展,但侵袭性真菌感染(IFI)仍然是实体器官移植受者发病和死亡的主要原因。引起IFI最常见的病原体是念珠菌属,其次是曲霉菌和隐球菌。近年来,IFI的流行病学已发生转变。在移植患者中,非白色念珠菌属念珠菌和非曲霉菌丝状霉菌越来越常见。最近还描述了IFI发病时间的变化。在RESITRA(西班牙移植感染网络)研究中,至少50%的侵袭性曲霉病(IA)感染和40%的侵袭性念珠菌感染在移植180天后被观察到。一些传统上被认为是迟发性感染的隐球菌感染病例在移植后早期也有发现。IFI导致的死亡率仍然很高,尤其是IA患者。然而,IFI诊断和预防方面的逐步改善已使死亡率降低。

相似文献

1
[Epidemiology of invasive fungal infection in solid organ transplant].[实体器官移植中侵袭性真菌感染的流行病学]
Rev Iberoam Micol. 2011 Jul-Sep;28(3):120-3. doi: 10.1016/j.riam.2011.06.003.
2
[Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].[实体器官移植受者中的念珠菌病、曲霉病及其他侵袭性真菌病]
Rev Iberoam Micol. 2011 Jul-Sep;28(3):110-9. doi: 10.1016/j.riam.2011.06.002.
3
[Invasive fungal infection in solid organ transplant].[实体器官移植中的侵袭性真菌感染]
Enferm Infecc Microbiol Clin. 2012 Dec;30(10):645-53. doi: 10.1016/j.eimc.2012.09.004. Epub 2012 Nov 3.
4
[Invasive fungal diseases in solid organ transplant recipients].[实体器官移植受者的侵袭性真菌病]
Rev Iberoam Micol. 2011 Jul-Sep;28(3):109. doi: 10.1016/j.riam.2011.06.001.
5
[General epidemiology of invasive fungal disease].[侵袭性真菌病的一般流行病学]
Enferm Infecc Microbiol Clin. 2012 Feb;30(2):90-8. doi: 10.1016/j.eimc.2011.09.004. Epub 2011 Nov 12.
6
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.实体器官移植受者侵袭性真菌感染的流行病学及结局
Transpl Infect Dis. 2010 Jun;12(3):220-9. doi: 10.1111/j.1399-3062.2010.00492.x. Epub 2010 Jan 25.
7
Invasive fungal infections in renal transplant recipients: about 11 cases.肾移植受者的侵袭性真菌感染:约11例。
J Mycol Med. 2013 Dec;23(4):255-60. doi: 10.1016/j.mycmed.2013.07.052. Epub 2013 Sep 21.
8
[Scedosporium apiospermum disseminated infection in a single lung transplant recipient].[1例肺移植受者播散性阿皮瘤状瓶霉感染]
Rev Iberoam Micol. 2011 Jul-Sep;28(3):139-42. doi: 10.1016/j.riam.2011.06.007.
9
[Selected risk factors of fungal infections in human populations].[人类群体中真菌感染的选定风险因素]
Wiad Parazytol. 2004;50(3):367-72.
10
[Retrospective analysis of invasive fungal infection in surgical intensive care unit].外科重症监护病房侵袭性真菌感染的回顾性分析
Zhonghua Yi Xue Za Zhi. 2010 Feb 9;90(6):382-5.

引用本文的文献

1
In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.米替福新在浮游和生物膜生长条件下对白色念珠菌的体外活性及在小鼠口腔念珠菌病模型中的体内疗效
Antimicrob Agents Chemother. 2015 Dec;59(12):7611-20. doi: 10.1128/AAC.01890-15. Epub 2015 Sep 28.